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A B S T R A C T
A total of 476 European isolates (310 Cryptococcus neoformans var. grubii, 150 C. neoformans var. neoformans, and
16 C. gattii species complex) from both clinical and environmental sources were analyzed by multi-locus se-
quence typing. Phylogenetic and population genetic analyses were performed. Sequence analysis identified 74
sequence types among C. neoformans var. neoformans (VNIV), 65 among C. neoformans var. grubii (56 VNI, 8
VNII, 1 VNB), and 5 among the C. gattii species complex (4 VGI and 1 VGIV) isolates. ST23 was the most frequent
genotype (22%) among VNI isolates which were mostly grouped in a large clonal cluster including 50% of
isolates. Among VNIV isolates, a predominant genotype was not identified. A high percentage of autochthonous
STs were identified in both VNI (71%) and VNIV (96%) group of isolates. The 16 European C. gattii species
complex isolates analyzed in the present study originated all from the environment and all belonged to a large
cluster endemic in the Mediterranean area. Population genetic analysis confirmed that VNI group of isolates
were characterized by low variability and clonal expansion while VNIV by a higher variability and a number of
recombination events. However, when VNI and VNIV environmental isolates were compared, they showed a
similar population structure with a high percentage of shared mutations and the absence of fixed mutations. Also
linkage disequilibrium analysis reveals differences between clinical and environmental isolates showing a key
role of PLB1 allele combinations in host infection as well as the key role of LAC1 allele combinations for survival
of the fungus in the environment. The present study shows that genetic comparison of clinical and environmental
isolates represents a first step to understand the genetic characteristics that cause the shift of some genotypes
from a saprophytic to a parasitic life style.
1. Introduction
The encapsulated basidiomycetes yeasts belonging to Cryptococcus
neoformans and Cryptococcus gattii species complexes are important
pathogens causing cryptococcosis, a fungal infection affecting primarily
immunocompromised hosts. Cryptococcosis is acquired from the en-
vironment by exposure of the host to sources contaminated by the
fungus such as soil, plant materials, and bird excreta. Dehydrated
blastospores and basidiospores produced by the fungus are able to reach
pulmonary alveoli and may cause a systemic disease by hematogenous
dissemination. Cryptococcal yeasts are also able to cross the blood-
brain barrier and cause meningitis and menigo-encephalitis that leads
to host death unless treated (Kwon-Chung et al., 2014). Both C. neo-
formans and C. gattii have been recognized as species complexes each
containing several lineages that are object of investigation for their
differences in genetic, pathogenic, epidemiological, and ecological
characteristics as well as their clinical manifestations. At present, five
major molecular types have been recognized within the C. neoformans
species complex: VNI, VNII, and VNB, all presenting the capsular an-
tigen A (serotype A) and classified as C. neoformans var. grubii; VNIV
presenting the capsular antigen D (serotype D) and classified as C.
neoformans var. neoformans; and VNIII which represents diploid and
aneuploid hybrids between the two varieties (AD hybrids). Cryptococcus
gattii species complex includes at least four molecular types, VGI (ser-
otype B), VGII (serotype B), VGIII (serotype B or C) and VGIV (majority
of serotype C) (Meyer et al., 2003, 2009). Since molecular typing has
been performed for only a small percentage of isolates (about 10%) of
the more than 68,000 isolates reported in the literature (Cogliati,
2013), it is likely that additional lineages will be found as more strains
are typed and their relationship with existing lineages are analyzed.
Hence the names “C. neoformans species complex” and “C. gattii species
complex” have been proposed to indicate that both species contain
genetically diverse lineages but it is premature to draw boundaries
between lineages to warrant each lineage as separate species. The status
of “species complex” was provisional for the sake of nomenclatural
stability until the vast majority of cryptococcal populations is analyzed
and the character of each lineage becomes readily identifiable (Kwon-
Chung et al., 2017). The proposed ‘species complex’ was in response to
an earlier proposal for a revision of cryptococcal taxonomy which was
based on the currently identified major lineages (Hagen et al., 2015,
2017). The proposed revised system classifies, the VNI, VNII and VNB
molecular types as C. neoformans, VNIV as C. deneoformans, VNIII as C.
neoformans× C. deneoformans hybrids; VGI as C. gattii, VGII as C. de-
teurogattii, VGIII (serotype B and C) as C. bacillisporus, a cluster of VGIII
serotype C as C. decagattii, and VGIV as C. tetragattii. Although this
newly proposed classification system has a merit for the progress in the
taxonomy of these pathogens within the genus Cryptococcus, it is pre-
mature as it is already encountering some difficulties revealed by the
most recent molecular studies. VNII, VNB, VGIII, and VGIV lineages
have been understudied in the past and only recently some results in-
dicate them to be highly heterogeneous. The recent study on VNI, VNII,
and VNB C. neoformans var. grubii isolates by whole genome sequencing
showed that VNB could be further separated in two lineages VNBI and
VNBII (Rhodes et al., 2017). Similar findings have been obtained for
VGIII and VGIV C. gattii isolates, showing that these also include dif-
ferent lineages (Cogliati et al., 2012a; Firacative et al., 2016; Nyazika
et al., 2016).
In Europe, as well as in most of the high-income countries, the
number of cases of cryptococcosis has decreased during the last two
decades since the introduction of high active anti-retroviral therapy,
which has drastically reduced the number of AIDS patients (ecdc.
europa.eu/en/publications-data/hivaids-surveillance-europe-2017-
2016-data). On the other hand, the population of patients with other
immunocompromising conditions, such as those with transplantation
(http://www.transplant-observatory.org/count2), hematological ma-
lignancies (Miranda-Filho et al., 2018) or autoimmune diseases (www.
niaid.nih.gov/sites/default/files/adccfinal.pdf), are on the rise. Cases of
cryptococcosis in these patients are often difficult to diagnose due to the
rarity and the different clinical manifestation of the disease (Pappas,
2013; George et al., 2018; Henao-Martìnez et al., 2018; Shuai et al.,
2018; Wang et al., 2018; Hamdam et al., 2018; Morse et al., 2018;
Florentino et al., 2018; Dioverti et al., 2018; Yamada et al., 2018; Swan
and Gottlieb, 2018; Posteraro et al., 2018). Furthermore, cryptococcosis
can also occur in immunocompetent hosts, especially when the infec-
tion is caused by C. gattii species complex VGI or VGII, making the di-
agnosis more complicated (Chen et al., 2014). Early diagnosis is critical
for effective therapy and patient management while delayed diagnosis
could hamper the therapeutic trajectory and increase the risk of death.
In Europe, most cases of cryptococcosis are caused by isolates of the
C. neoformans species complex with VNI being the most prevalent
molecular type, followed by VNIV, and VNIII hybrids (Viviani et al.,
2006; Cogliati, 2013; Sanchini et al., 2014; Desnos-Ollivier et al.,
2015). A higher prevalence of VNIV, and consequently of VNIII hybrids,
than in other continents is a peculiar characteristic of Cryptococcus
epidemiology in Europe (Cogliati, 2013). A recent niche modeling
analysis suggested that VNIV isolates are well adapted to European
climatic conditions characterized by areas with sub-continental climate,
which provides the optimal ecological niche for this pathogen (Cogliati
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et al., 2017). Furthermore, VNIII isolates resulting from hybridization
of VNI and VNIV genotypes could play an important role in the evo-
lution of the C. neoformans species complex since it represents a me-
chanism of generating new genetic variability and therefore potentially
highly virulent strains (Sun and Xu, 2009; Shahid et al., 2008; Cogliati
et al., 2012b).
Cases of cryptococcosis due to C. gattii species complex isolates were
also reported in Europe, with VGI being the most prevalent molecular
type (Hagen et al., 2012; Cogliati, 2013). In addition, some VGII iso-
lates were the cause of infection in cases of cryptococcosis most prob-
ably acquired outside the continent (Hagen et al., 2010, 2012). In
contrast, most infections due to VGI isolates were autochthonous
(Hagen et al., 2012) as confirmed by recent European environmental
surveys that showed the presence of VGI isolates in live trees and soil
(Chowdhary et al., 2012; Colom et al., 2012; Linares et al., 2015;
Cogliati et al., 2016a; Montagna et al., 2018). Monitoring the dis-
tribution of genotypes of C. neoformans and C. gatti species complexes in
the European and Mediterranean environment is crucial to evaluate the
evolution of this pathogen which seems capable to rapidly colonize new
habitats. This is illustrated by a VGI and VGII outbreak, which was first
detected in 1999 in Vancouver Island (Bartlett et al., 2012) and is now
spreading along the Northern Pacific Coast of North America
(Engelthaler et al., 2014). The outbreak is mainly due to variants of the
VGII genotype (VGIIa, VGIIb, and VGIIc) that were likely imported from
South America (Hagen et al., 2013; Billmyre et al., 2014; Engelthaler
et al., 2014; Souto et al., 2016; Roe et al., 2018) and has adapted to the
temperate climate of the Vancouver Bay (Mak et al., 2010). The ability
of VGI and VGII isolates to potentially behave as primary pathogens
infecting healthy patients has alarmed public health authorities.
A recent niche modeling study showed that Europe and the non-
European Mediterranean area (Northern Africa, Israel, Lebanon, Syria and
Turkey) present optimal bioclimatic conditions for the survival in the en-
vironment of both C. neoformans and C. gattii species complexes with
several areas where VNI, VNIV, and VGI can coexist (Cogliati et al., 2017).
Therefore there is a potential risk for the emergence of new virulent
genotypes or the establishment of virulent genotypes from other con-
tinents. In 2013 the Screen (Survey of CRyptococcosis through a European
Epidemiological Network) Project, including about 200 European re-
searchers, was created with the purpose of monitoring the epidemiology of
Cryptococcus and cryptococcosis in Europe through data and isolate col-
lection from clinical and veterinary cases as well as from environmental
surveys (sites.google.com/view/screenprojectcryptococcus). The present
study reports the first population genetic analysis carried out integrating
all multi-locus sequence typing (MLST) data available for European iso-
lates comparing the different genetic populations in both clinical and en-
vironmental isolates.
2. Materials and methods
2.1. Isolates
In the present study 476 isolates of C. neoformans and C. gattii
species complexes from clinical (n= 275), veterinary (n= 16), and
environmental (n= 185) sources were investigated. Isolates were from
Italy (n= 159), France (n=118), Germany (n=96), Turkey (n=41),
Greece (n=30), Spain (n=16), Cyprus (n=4), Denmark (n=4),
Belgium (n=4), Libya (n= 3), and Portugal (n= 1) (Table 1). En-
vironmental isolates were recovered mainly from arboreal samples
(n=176), eight were from pigeon droppings and one from dust
(Cogliati et al., 2016a, 2016b). Most of the isolates were mating type α
and included 36 mating type a isolates (three VNI and 33 VNIV)
(Table 1).
2.2. MLST analysis
All isolates were genotyped using the MLST scheme standardized by
the “ISHAM Working Group for Genotyping of C. neoformans and C.
gattii” (Meyer et al., 2009). Six housekeeping loci (CAP59, GPD1, LAC1,
PLB1, SOD1, and URA5) and the IGS1 rDNA intergenic region were
amplified and sequenced. Sequences were then compared with those
present in the Cryptococcus MLST database (www.mycologylab.org) in
order to assign an allele number. The combination of the seven-allele
numbers of each isolate was also searched in the MLST database and a
sequence type (ST) was assigned. Allele types and STs, which were not
present in the MLST database, were sent to the curator of the database
in order to assign a new allele or ST code. Most of the environmental
isolates (176 isolates) were sequenced in the present study (Supple-
mentary material, Table S1), whereas sequences of clinical isolates from
Italy, France, Germany and data from Belgium and Denmark were ob-
tained from previously reported results (Hagen et al., 2012; Cogliati
et al., 2013; Danesi et al., 2014; Sanchini et al., 2014; Desnos-Ollivier
et al., 2015; Cogliati et al., 2016b). The sequences of each allele type
are available at the Cryptococcus MLST database and, furthermore, se-
quences of the new allele types were deposited in GenBank (www.ncbi.
nlm.nih.gov). Accession numbers are reported in the Supplementary
material, Table S1.
Supplementary data associated with this article can be found, in the
online version, at https://doi.org/10.1016/j.fgb.2019.04.001.
2.3. Phylogenetic analysis
The concatenated sequences of the seven MLST loci of each isolate
were aligned using Clustal Omega (www.ebi.ac.uk). The alignment file
was then imported in MEGA software (www.megasoftware.com) for
phylogenetic analysis. The maximum likelihood algorithm was used to
infer a phylogenetic tree for both C. neoformans and C. gattii species
complex isolates. Additional MLST sequence data from a set of VGI
isolates of the C. gattii species complex previously reported in Europe
were included in the phylogenetic analysis (Hagen et al., 2012). STs of
European VGII and VGIII isolates were not included in the phylogenetic
tree since they were already analyzed and discussed by Hagen et al.
Table 1
Geographical origin, source, and molecular type of the 476 C. neoformans and C.
gattii species complex isolates investigated in the present study.
Molecular types Total
VNI VNII VNB VNIV VGI VGIV
Belgium C 2 2
E 2 2
Cyprus C 0
E 4 4
Denmark C 0
E 4 4
France C 38 7 70 115
E 3 3
Germany C 77 1 15 93
E 3 3
Greece C 0
E 6 18 6 30
Italy C 49 3 1 12 65
E 71 19 4 94
Libya C 0
E 1 2 3
Portugal C 0
E 1 1
Spain C 0
E 9 1 5 1 16
Turkey C 0
E 37 4 41
Total C 164 11 1 99 0 0 275
E 132 2 0 51 15 1 201
Mating type α 293 13 1 116 12 1 436
a 3 0 0 33 3 0 40
C=Clinical isolates; E=Environmental isolates.
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(2012). Statistical analysis was performed by bootstrap analysis with
1000 replicates. The same alignment files were imported into Network
4 software (www.fluxus-engineering.com) to construct a median-
joining network for VNI and VNIV isolates. In addition, allele type and
ST data were imported in Phyloviz software (www.philoviz.net) to
construct a minimum spanning tree, using the goeBurst algorithm, for
C. neoformans var. grubii, C. neoformans var. neoformans and the C. gattii
species complex.
2.4. Population genetics analysis
To perform population genetics analysis isolates were stratified by
different categories: by molecular type (VNI, VNII, VNIV), by source
(clinical and environmental/veterinary, ENV), by molecular type and
source (clinical VNI, ENV VNI, clinical VNIV, and ENV VNIV), and by
country (France, Germany, Greece, Italy, Spain, and Turkey).
Intra- and inter-population genetic variability was estimated by
several parameters: number of haplotypes (h), number of segregating
sites (S), haplotype diversity (Hd), nucleotide diversity (π), and average
number of nucleotide differences (k). The neutrality tests Tajima's D, Fu
& Li's D, and Fu & Li's F, were also calculated to verify if populations
were at equilibrium or selection mechanisms were occurring. Minimum
number of recombination events for each locus in each population was
also estimated. In addition, number of fixed mutations, number of
shared mutations, and the number of monomorphic mutations in one
population and polymorphic in the other, were calculated to estimate
genetic divergence between populations. Inter-population comparison
of nucleotide diversity was also performed. Finally, a map showing the
most probable routes of spreading of European genotypes was inferred
comparing the VNI populations of the countries with a number of iso-
lates ≥10. Statistical analysis was performed calculating FST index to
verify genetic exchange between VNI populations of different countries.
The genotypes which were present in more than one country, were
shown in the map as well as the statistical support to justify the
spreading from a country to another. All parameters and tests were
calculated using DNAsp v5.10.1 software (www.ub.edu/dnasp).
Linkage disequilibrium test between pairs of loci was performed by
Arlequin software v3.0 (cmpg.unibe.ch/software/arlequin3) to eval-
uate the level of linkage between loci in a population.
3. Results
3.1. Most of the STs are exclusive of Europe and ST23 is the most common
MLST analysis identified 74 STs among C. neoformans var. neofor-
mans (VNIV), 65 STs among C. neoformans var. grubii (56 VNI, 8 VNII, 1
VNB), and 5 STs amongst the C. gattii species complex (4 VGI and 1
VGIV) isolates. Whatever the origin, ST23 was the most common gen-
otype (22%) among the VNI isolates followed by ST63 (10%), whereas
the other STs showed a lower frequency (0.3–7%) (Table 2). In contrast,
among the VNIV isolates, a prevalent genotype was not identified, with
the highest frequency observed for ST499 and ST160 (10% and 8%,
respectively), followed by ST35 (7%), ST116 (6%), and ST112 (5%).
Most of the VNIV STs (58/77, 75%) were represented by only one
isolate. ST160 and ST499 were the most frequent genotypes (20% and
26%, respectively) among VNIV ENV isolates, whereas among clinical
isolates they showed only 3% and 0% frequency, respectively (Table 3).
In addition, VNI isolates included nine STs that were present only
among ENV isolates, and 37 STs were present only among clinical
isolates. Amongst VNIV isolates 16 STs were exclusive to the ENV
group, and 57 to the clinical group. Furthermore, comparing European
STs results with those globally reported in the literature we found that
71% of VNI and 96% of VNIV STs analyzed in the present study were
exclusive to Europe. Among the 13 VNII isolates eight STs were iden-
tified: ST40, ST41, ST42, ST43, ST96, ST106, ST107, and ST490. Fi-
nally, the 16 C. gattii species complex isolates analyzed in the present
study were all from the environment, four isolates from Italy belonged
to genotype ST156 (VGI) and ST197 (VGI), six from Spain to ST194
(VGI) and ST367 (VGIV), and six from Greece to ST204 (VGI).
3.2. Most of VNI STs are included in a large clonal cluster
Fig. 1A shows the four clonal clusters (CCs) identified by goeBurst
algorithm among VNI isolates. The main cluster was CC23 including 30
STs and 98 isolates (50%), followed by CC5 with 9 STs and 29 isolates
(15%), CC69 with 4 STs and 25 isolates (13%), and CC75 with 3 STs
and 16 isolates (8%). The remaining 128 isolates representing 10 STs
were not clustered.
Among VNIV isolates only four CCs were identified (Fig. 1B): CC135
including 5 STs and 14 isolates (9%), CC160 with 3 STs and 14 isolates
(9%), CC499 including one ST and 16 isolates (10%), and CC121 with 5
STs and 14 isolates (9%). Seven CCs including 2 STs each were also
identified, whereas others 49 STs were not clustered. In addition, the
minimum spanning tree showed that 16% (9/56) of the STs in VNI
isolates included both clinical and ENV isolates whereas only 5% (4/77)
were present in VNIV isolates (p < 0.05) (Tables 2 and 3, Fig. 1A and
1B).
With respect to the geographical origin, 11 VNI STs were re-
presented by isolates from different countries, including ST63 dis-
tributed in six countries, ST58 in five countries, and ST5, ST23, and
ST69 in four countries (Fig. 1A). On the contrary, among VNIV isolates
only two STs (ST160 and ST135) were distributed in three different
countries (Fig. 1B).
The 15 C. gattii VGI isolates clustered in two CCs: CC156 including
isolates from Italy and Spain belonging to ST156, ST197, and ST194,
and a second cluster including isolates from Greece, which all belonged
to ST204 (Fig. 1C).
Table 2
Sequence type frequency among clinical and environmental VNI isolates.
Sequence type (ST) No. of isolates (%)
Clinical
(n= 164)
Environmental
(n=132)
Total
(n= 296)
23 27 (16) 40 (31) 67 (22)
63 15 (9) 14 (11) 29 (10)
69 19 (11) 1 (0.8) 20 (7)
2 13 (8) 5 (4) 18 (6)
5 15 (9) 3 (2) 18 (6)
61 16 (10) 1 (0.8) 17 (6)
264 – 16 (12) 16 (5)
232 – 13 (10) 13 (4)
32 10 (6) – 10 (3)
58 5 (3) 4 (3) 9 (3)
68 2 (1) 3 (2) 5 (2)
75 5 (3) – 5 (2)
46 4 (2) – 4 (1)
494 – 4 (3) 4 (1)
544 – 3 (2) 3 (1)
45, 67 3 (2) – 3 (1)
56, 289 2 (1) 1 (0.8) 3 (1)
4, 71, 104, 105 2 (1) – 2 (0.7)
226, 341, 493,
533, 547
– 2 (2) 2 (0.7)
6, 37, 55, 59, 62,
64, 65, 70, 72,
77,
81, 84, 138,
174, 250,
288, 290, 488,
491, 492,
495, 545, 546,
548, 549,
550, 551, 552
1 (0.6) – 1 (0.3)
STs indicated in bold are exclusive of Europe.
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3.3. Some STs do not fit in the four major clusters VNI, VNII, VNB, and
VNIV
Maximum likelihood phylogenetic reconstruction, performed in-
cluding the 139 STs of the C. neoformans species complex of the present
study, identified four major molecular types VNI, VNII, VNB, and VNIV,
which were supported by more than 90% of trees produced by boot-
strap analysis. However, some STs presented an ambiguous topology
either among VNIV (ST496, ST506, ST507, ST508, ST516 and ST520),
VNI (ST232, and ST488) or VNII (ST42 and ST107) (Fig. 2).
When the four VGI STs identified in the present study were com-
pared to those previously reported in Europe, they were grouped in a
large cluster including STs mostly present exclusively in Europe. In this
group only ST56 and ST58 included isolates from other continents.
Isolates belonging to ST225, ST232, and ST57 belonged to other clus-
ters and were probably imported from other continents. The VGIV
isolate belonging to ST367 was unique and was different from any other
global isolate so far reported (Fig. 3).
Network analysis showed that the VNII group of isolates is not a
homogenous group but includes genotypes with high genetic diversity
that has some genetic relationship both with VNI and VNB groups
(Fig. 4). In addition, comparison of network reconstruction performed
for VNI and VNIV isolates showed the different genetic evolution of
these two groups. VNI isolates displayed numerous large clonal clusters
and few dispersed genotypes, in contrast VNIV isolates showed a high
number of dispersed genotypes and few small CCs (Fig. 4).
3.4. High Hd in both VNI and VNIV groups of isolates
Table 4 shows the genetic indexes calculated for the different group
of isolates investigated in the present study. Comparison of VNI, VNII,
and VNIV isolates showed that VNIV and VNI have the highest Hd
values which was lower in VNII isolates. In contrast, the π value in VNII
isolates was higher than that found in VNI with a k of 12.4 versus 8.6,
respectively. Neutrality test carried out with three different algorithms
showed that only VNIV isolates are under selective pressure. In-
dependent analysis of each of the seven MLST loci showed that there
was no polymorphism of LAC1 in VNII isolates, and a low Hd was also
observed for the GPD1 locus in VNIV and the SOD1 locus in VNI iso-
lates. The IGS1 locus was the most variable in the three group of isolates
with VNIV showing the highest value followed by VNII and VNI (Sup-
plementary material Fig. S1A). When the C. neoformans species complex
isolates were grouped in two categories, clinical and ENV isolates, no
differences in Hd, π, and neutrality test were found. A similar result was
confirmed by single loci analysis, except for the GPD1 locus, which
showed a low Hd in the ENV isolates (Supplementary material
Fig. S1B). Stratification of VNI and VNIV by clinical and ENV isolates
revealed differences in genetic parameters. The group including clinical
VNIV isolates showed the highest Hd, whereas the lowest value was
observed in the group including ENV VNI isolates. The other two ca-
tegories (clinical VNI and ENV VNIV) had a similar Hd intermediate
value. A high π value (0.01048) was observed in ENV VNIV isolates, but
lower values were calculated for ENV VNI and clinical VNIV isolates,
and a very low value (0.00195) was found for the clinical VNI group.
Neutrality tests showed that selective pressure is occurring in all groups
of isolates except the clinical VNI group. Differences in Hd were also
observed analyzing single loci (Supplementary material Fig. S1C). The
GDP1 locus showed a very low Hd values in the ENV VNI group com-
pared to the other ones. The greatest inter-population difference in Hd
values was found for the IGS1 locus with the two VNIV group of isolates
(clinical and ENV) showing a value ranging from 0.7 to 0.8 and VNI
isolates showing a value lower than 0.3. A similar difference, but to a
minor extent, was observed in the URA5 locus where the calculated
values were 0.8 for the VNI groups and 0.4–0.6 for VNIV. In both
CAP59 and SOD1 loci Hd values were decreasing in the following order:
ENV VNIV > clinical VNIV > ENV VNI > clinical VNI. In contrast,
all groups showed a similar Hd in LAC1 and PLB1 loci.
Stratification of isolates by country revealed that isolates from
France had the highest Hd and π values, whereas those from Greece had
the lowest Hd value but a high π value. The other groups analyzed
(Italy, Germany, Spain, and Turkey) showed similar Hd and π values
ranging from 0.84 to 0.95 and from 0.026 to 0.041, respectively.
Selective pressure was observed in Italy, France, Turkey, and Spain but
not in Germany and Greece.
3.5. Linkage disequilibrium of PLB1 in VNI isolates and LAC1 in clinical
VNIV isolates
Linkage disequilibrium test between pairs of loci performed for the
VNI, VNII, and VNIV isolates, showed that in both VNI and VNIV iso-
lates most of loci were linked, but some differences were observed. In
the VNI group the PLB1 locus was linked to each of the other loci,
whereas this was not true in the VNIV group. By contrast the LAC1 and
SOD1 loci showed a high percentage of linkage in VNIV isolates, but not
in the VNI group. Pairwise comparison of loci in VNII isolates revealed
that most of the loci were not linked to each other (Fig. 5).
Stratified analysis by clinical and ENV of VNI isolates revealed that
linkage disequilibrium pattern of the ENV group was identical to that of
the whole VNI group of isolates, in contrast the clinical VNI group
showed mostly non-linked loci, except for PLB1. Amongst VNIV iso-
lates, the clinical and ENV groups showed a difference in the LAC1
linkage pattern, which was only present in the former group of isolates
but not in the latter one (Fig. 5).
Table 3
Sequence type frequency among clinical and environmental VNIV isolates.
No. of isolates (%)
Sequence type (ST) Clinical
(n= 99)
Environmental
(n= 51)
Total (n= 150)
499 – 16 (31) 16 (10)
160 3 (3) 9 (18) 12 (8)
135 8 (8) 2 (4) 10 (7)
116 9 (9) – 9 (6)
121 7 (7) – 7 (5)
112 4 (4) 2 (4) 6 (4)
114, 122 4 (4) – 4 (3)
553 – 4 (9) 4 (3)
180 2 (2) 1 (2) 3 (2)
110, 125, 168 3 (3) – 3 (2)
294 – 2 (4) 2 (1)
133, 134, 165, 508 2 (2) – 2 (1)
251, 252, 496, 498,
500,
517, 522, 523,
524, 554
– 1 (2) 1 (0.7)
108, 111, 118, 119,
120,
123, 124, 128,
129, 130,
131, 132, 136,
154, 155,
156, 157, 158,
159, 161,
162, 163, 164,
166, 167,
170, 178, 179,
181, 279,
486, 487, 505,
506, 507,
509, 510, 512,
514, 515,
516, 518, 519,
520, 530,
531
1 (1) – 1 (0.7)
STs indicated in bold are exclusive of Europe.
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Fig. 1. Minimum spanning tree showing the main clonal clusters (CC) linked by a single locus difference. Isolates have been identified according to the source and the
country of isolation. Each circle represents a unique sequence type (ST), and the circle size is proportional to the number of isolates within each ST.
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3.6. Environmental isolates are the most recombinants in both VNI and
VNIV groups
The minimum number of recombination events, calculated for each
group of isolates, is reported in Table 5. Recombination was observed in
VNIV isolates but not in VNI and VNII groups. The LAC1 locus was the
most recombinant one whereas no recombination events were found in
the PLB1 locus. Comparison of clinical and ENV isolates showed re-
combination in both groups with the LAC1 locus having 21 re-
combination events in the ENV group versus 7 in the clinical one. Both
clinical and ENV VNIV isolates had recombination at all loci except
PLB1, whereas in the VNI isolates only the ENV group showed three
recombinant loci (LAC1, PLB1, and SOD1). Finally, recombination
events were observed in all countries, except in Spain.
3.7. Comparison of environmental VNI and VNIV isolates showed a high
rate of shared mutations and no fixed mutations
The first row of graphics in Fig. 6 shows the comparison between
VNI, VNII, and VNIV isolates. VNIV versus VNI and VNII showed a high
percentage of fixed mutations and a low percentage of shared mutations
confirming the genetic distance between these group of isolates. Fur-
thermore, in both comparisons VNIV showed the highest percentage of
polymorphic sites compared to the other two group of isolates. Genetic
comparison between VNI and VNII showed a lower percentage of fixed
mutations and a higher percentage of shared mutations compared to the
previous two analyses, and that VNI was more polymorphic than VNII
isolates. Comparing clinical versus ENV VNI isolates, and clinical versus
ENV VNIV isolates, ENV isolates were more polymorphic than clinical
ones, especially ENV VNI isolates, and no fixed mutations were ob-
served. The last two comparisons showed the most interesting results.
VNI versus VNIV clinical groups presented a high percentage of fixed
mutations and a lower percentage of shared mutations as expected,
with clinical VNIV being more polymorphic than VNI. On the contrary,
comparisons between ENV isolates surprisingly did not present any
fixed mutations and a high percentage of shared mutations, with VNI
being more polymorphic than VNIV.
Inter-population comparison of nucleotide diversity is shown in
Fig. 7. Clinical and ENV isolates presented an overlapping nucleotide
diversity curve (k= 196 versus 173, respectively) (Fig. 7A and Table 4).
Fig. 2. Maximum likelihood phylogenetic tree inferred using the concatenated
sequences of the seven MLST loci (CAP59, GPD1, LAC1, PLB1, SOD1, URA5, and
the IGS1 region) of the Cryptococcus neoformans species complex sequence types
(ST) investigated in the present study. Bootstrap values, based on 1000 re-
plicates, are reported at each branch node. Red dots indicate STs including
clinical isolates, green dots environmental isolates, and blue dots veterinary
isolates. STs highlighted in light yellow include mating type a isolates. Black
arrows indicate STs with an ambiguous topology. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web
version of this article.)
0.005
Fig. 3. Maximum likelihood phylogenetic tree inferred using the concatenated
sequences of the seven MLST loci (CAP59, GPD1, LAC1, PLB1, SOD1, URA5, and
the IGS1 region) of the Cryptococcus gattii species complex sequence types (ST)
investigated in the present study (marked in light red). STs are compared with
STs from European VGI isolates previously reported by other authors (Hagen
et al., 2010) who analyzed also further VGII and VGIII isolates not included in
the current analysis. Bootstrap values, based on 1000 replicates, are reported at
each branch node. Black squares indicate European autochthonous STs. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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When these two group of isolates were compared by considering only
VNI isolates, the difference became evident (k= 6 versus 24, respec-
tively) with clinical isolates presenting a lower nucleotide diversity in
most of the loci, except LAC1 and PLB1, compared to ENV ones (Fig. 7B
and Table 4). On the contrary, the nucleotide diversity in VNIV isolates
was similar (k= 17 in clinical isolates versus 24 in environmental ones,
Table 4) with low values of clinical VNIV only for LAC1 and SOD1 loci
(Fig. 7C).
Fig. 7D shows a great difference in nucleotide diversity comparing
VNI versus VNIV isolates (k= 9 and 21, respectively). This difference
was not so evident when the two group of isolates (k= 23 in VNI and
k= 24 in VNIV) where compared in the ENV group (Fig. 7E and
Table 4). In the clinical group nucleotide diversity was very low in both
group of isolates (k= 6 in VNI and k= 17 in VNIV) with the exception
of higher values for GPD1 and IGS1 loci in the VNIV group (Fig. 7F and
Table 4).
3.8. Genetic flow analysis supports the spreading in Europe of the most
common VNI STs
Results of genetic flow analysis showed that, in Europe, the main
genetic flows, which are supported by FST statistics, were identified
between Italy, Germany, Spain, and Turkey. Analyzing the most fre-
quent STs in Europe, that is ST23, ST63, and ST69, and ST5, all be-
longing to the VNI molecular type, it was possible to infer the main
routes of spreading across the continent (Fig. 8). ST23 was found in
Italy, Germany, Turkey and France with a spreading direction South to
North or vice versa. ST63 was the most spreading genotype, presenting
an additional directional component towards or from Western Europe.
ST69 was primarily confined in central Europe with main genetic flows
between Italy and Germany. ST5 spreads mainly from Germany towards
Southern and Western Europe.
Fig. 4. Network analysis showing genetic relationships between VNI, VNII and VNB isolates (right-side panel) and between VNI and VNIV isolates (left-side panels).
Each circle represents a sequence type, the size of the circles is proportional to the numbers of isolates, and the length of each branch is proportional to genetic
distance.
Table 4
Parameters values of population genetics calculated for the populations investigated in the present study.
Population (no. of isolates) Polymorphic
sites (S)
No. of
mutations
(Eta)
No. of
haplotypes
Haplotype
diversity (Hd)
Average no. of
nucleotide
difference (K)
Nucleotide
diversity (π)
TajimaD FuLiD FuLiF
VNI (n=296) 102 102 54 0.917 8.67526 0.00264 −1.0652 −1.6819 −1.6536
VNII (n= 13) 43 43 8 0.897 12.41026 0.0037 0.3017 0.7634 0.7318
VNIV (n=150) 386 420 76 0.975 20.87302 0.00615 −2.3134** −6.8658** −5.6255**
CLINICAL (n= 275) 640 675 99 0.969 195.99388 0.05824 3.3209** 0.2625 2.2016**
ENVIRONMENTAL (n=185) 602 642 55 0.921 172.85493 0.05015 1.9673* 0.5456 1.4837*
VNI CLINICAL (n=164) 43 43 31 0.919 6.21739 0.00195 0.0795 −0.3883 −0.2285
VNI ENVIRONMENTAL (n= 132) 492 499 29 0.859 23.72921 0.00697 −2.3989** 2.4411** 0.2253
VNIV CLINICAL (n=99) 254 266 55 0.977 17.00417 0.00723 −1.5402 −3.0985* −2.9078*
VNIV ENVIRONMENTAL (n= 51) 415 450 25 0.909 24.39592 0.01048 −2.166* −3.7735** −3.7839**
FRANCE (n= 118) 562 583 63 0.984 206.30268 0.06193 3.9762*** 2.2139** 3.6125**
GERMANY (n= 96) 557 574 26 0.901 136.09888 0.04178 1.5002 1.3588 1.7042*
GREECE (n= 24) 544 569 11 0.770 187.37 0.05496 1.2337 0.8888 1.1779
ITALY (n= 155) 556 578 43 0.928 134.18172 0.03963 1.5467 2.0203** 2.1465**
SPAIN (n= 10) 491 493 8 0.956 85.53333 0.02593 −2.0918** −2.4981** −2.7097**
TURKEY (n=41) 538 552 11 0.840 103.38902 0.03157 −0.1907 1.6077** 1.1366
* p < 0.05.
** p < 0.01.
*** p < 0.001.
M. Cogliati, et al. Fungal Genetics and Biology 129 (2019) 16–29
23
4. Discussion
The present study is the largest genetic population analysis carried
out in Europe and the Mediterranean area integrating most of the
available MLST datasets from clinical and environmental isolates re-
ported in this geographical region. The analyzed collection of isolates
included mainly isolates belonging to the C. neoformans species com-
plex (VNI, VNII, VNIV and one VNB) and a few environmental C. gattii
species complex isolates.
The results reported above show a high genetic diversity among the
C. neoformans species complex isolates here investigated, confirming
previous MLST studies carried out on clinical isolates in Italy, France,
and Germany (Cogliati et al., 2013; Sanchini et al., 2014; Desnos-
Ollivier et al., 2015). The high haplotype diversity of VNI isolates is
comparable to those calculated for other continents but higher than that
observed in Asia (Khayhan et al., 2013; Ferreira-Paim et al., 2017).
However, the present study includes more isolates from both clinical
and environmental sources. In addition, a large number of clinical and
environmental VNIV isolates were included in this study providing new
insights about genetic differences and relationships with VNI isolates.
Our results show a major clonal cluster (CC23) being present in
Europe including 50% of all VNI isolates with ST23 and ST63 being the
most frequent genotypes. By contrast, fewer and smaller CCs are pre-
sent amongst VNIV isolates with no prevalent genotypes. Interestingly,
most of the VNI and VNIV STs (71% and 96%, respectively) seem un-
ique to Europe and absent in other continents suggesting that these
genotypes are not yet spreading outside the continent. On the other
hand, some VNI STs belonging to CC5, CC69, and CC75 seem to be
Fig. 5. Linkage disequilibrium between pair of loci calculated by Arlequin v3.0. Each graphic represents the results obtained in a different group of isolates. Red
squares indicate that two loci are linked whereas green squares indicate no linkage. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
Table 5
Minimun number of recombination events calculated among populations investigated in the present study.
Population CAP59 GPD1 IGS1 LAC1 PLB1 SOD1 URA5 Total
VNI (n=296) 0 0 0 0 0 0 0 0
VNII (n= 13) 0 0 0 0 0 0 0 0
VNIV (n=150) 4 2 6 17 0 3 5 37
CLINICAL (n= 275) 5 3 9 7 1 3 5 33
ENVIRONMENTAL (n=185) 4 2 5 21 1 4 3 40
VNI CLINICAL (n=164) 0 0 0 0 0 0 0 0
VNI ENVIRONMENTAL (n= 132) 0 0 0 1 1 3 0 5
VNIV CLINICAL (n=99) 4 0 5 1 0 3 5 18
VNIV ENVIRONMENTAL (n= 51) 2 12 5 11 0 1 2 28
FRANCE (n= 118) 3 3 6 2 1 2 3 20
GERMANY (n= 96) 2 2 1 3 0 1 2 11
GREECE (n= 24) 0 2 4 9 0 0 0 15
ITALY (n= 155) 2 3 6 1 1 3 2 18
SPAIN (n= 10) 0 0 0 0 0 0 0 0
TURKEY (n=41) 0 1 2 3 1 2 0 9
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imported from other continents and are now spreading in Europe
throughout Germany, France, and Italy.
Phylogenetic analysis showed that isolates from Europe and the
Mediterranean area belonging to the C. neoformans species complex are
grouped in four clusters corresponding to the molecular types VNI,
VNII, VNB, and VNIV, and revealed some isolates that showed an un-
expected branch topology suggesting that their genome contains ge-
netic remains of ancestral groups of the C. neoformans species complex.
These findings are supported by other studies which reported these kind
of isolates (Cogliati et al., 2016b; Rhodes et al., 2017; Muñoz et al.,
2018,). Further investigation of these isolates is needed to clarify their
origin.
Network analysis, supported by haplotype diversity and re-
combination events values, confirmed the different genetic population
structure of VNI and VNIV isolates, the former presenting a primarily
clonal structure and the latter a recombinant structure. The same
conclusions are reported by previous studies carried out with French
clinical isolates and in a number of global VNIV isolates (Desnos-
Ollivier et al., 2015; Cogliati et al., 2016b). In the present study genetic
features of clinical and environmental isolates were compared for the
first time providing new insights about genetic relationships and dif-
ferences between VNI and VNIV isolates. The obtained results show that
VNIV isolates present a higher genetic diversity compared to VNI, and
that VNI and VNIV environmental isolates show a higher genetic di-
versity compared to their respective clinical isolates. These results
suggest that in Europe VNIV strains has found favorable environmental
conditions and have increased their genetic diversity most likely thanks
to sexual recombination due to the presence of both mating type a and
α in the environment (Cogliati et al., 2013, 2016a). In addition, recent
studies showed that VNIV strains have a higher probability to be re-
covered in the areas of Europe characterized by a sub-continental cli-
mate due to tolerance of lower temperatures than VNI (Cogliati et al.,
2017). Similarly, the higher genetic diversity of ENV VNI compared to
clinical VNI could be explained with a residual ability of environmental
isolates to sexually recombine. This is confirmed by the analysis of
recombination events which were identified only in the environmental
VNI isolates. In addition, the presence of VNI mating type a and mating
type α isolates in the European environment and their ability to mate
were shown previously (Cogliati et al., 2016a).
Interesting conclusions were drawn by the analysis of linkage dis-
equilibrium results and nucleotide diversity indexes comparing ENV
and clinical groups in VNI and VNIV isolates. In the clinical VNIV iso-
lates, the LAC1 locus presents a full linkage with all other loci but this
was not observed in ENV VNIV isolates. This means that only some
alleles of the LAC1 locus are represented amongst the clinical isolates,
probably due to selective pressure. On the contrary, in ENV isolates, the
LAC1 locus presents a higher variability of combinations that could be
explained by the necessity of the fungus to adapt to a wide range of
substrates to which it is exposed in the environment. Nucleotide di-
versity values of the LAC1 locus also support this hypothesis as π values
of clinical VNIV are lower than those observed in ENV VNIV isolates. A
recent study on the LAC1 gene in a set of VNIV strains confirms these
Fig. 6. Inter-population genetic analysis inferred by DNAsp v5.10.1. In each comparison four parameters are represented with different colors: percentage of fixed
mutations, percentage of shared mutations, percentage of polymorphic sites in population 1 and monomorphic in population 2, and percentage of polymorphic sites
in population 2 and monomorphic in population 1.
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results, reporting an association between specific sequence poly-
morphisms in the LAC1 gene and the level of melanin production
(Samarasinghe et al., 2018).
Linkage disequilibrium and nucleotide diversity analyses of VNI
isolates identified a significant difference between the clinical and ENV
groups. Clinical isolates do not show linkage between any locus, except
for the PLB1 locus, whereas most of the loci in ENV isolates, including
the PLB1 locus, are linked. Therefore, in both group of isolates, the
PLB1 locus showed a high level of linkage suggesting that evolution has
selected a restricted set of PLB1 alleles that have been conserved
amongst the environmental isolates and that could play an important
role in the parasitic phase of the fungal life cycle. Furthermore, the
absence of linkage between the other loci observed in clinical VNI
isolates suggests that a multitude of genotype combinations are able to
cause infection conversely to what is observed in clinical VNIV isolates
where linkage between loci limits the possible combinations. This is
also supported by the significant difference observed between VNI and
VNIV in the percentage of STs containing both clinical and
environmental isolates (16% versus 5%, respectively). These genetic
differences between VNI and VNIV isolates could be the basis of their
different ability to cause infections, with VNI being the most prevalent
molecular type causing cryptococcosis globally (Cogliati, 2013). Inter-
population comparisons revealed that the major source of poly-
morphism is the environment for both VNI and VNIV isolates, having
93% and 53% of polymorphic sites, respectively, observed in ENV
isolates. This suggests that environmental stress is more effective to
generate new genotypes than host condition stress. Our results also
showed that, although clinical VNI and clinical VNIV isolates are ge-
netically divergent with 54% fixed mutations, no fixed mutation has
been observed by comparing environmental isolates of VNI and VNIV
which presented 25% shared mutations. Therefore, ENV VNI and VNIV
isolates are less genetically divergent than clinical ones. At present,
genetic population studies on C. neoformans species complex reporting a
high genetic divergence between VNI and VNIV isolates are mostly
based on clinical isolates, taking in scarce consideration of environ-
mental isolates. By contrast, the present study carried out a more
Fig. 7. Variation of nucleotide diversity along the seven-loci concatenated sequences in VNI and VNIV clinical and environmental/veterinary (ENV) isolates. Portion
of sequence covered by each of the seven loci is indicated on X ax. A. Comparison between clinical and ENV isolates. B. Comparison between clinical VNI and ENV
VNI isolates. C. Comparison between clinical VNIV and ENV VNIV isolates. D. Comparison between VNI and VNIV isolates. E. Comparison between ENV VNI and ENV
VNIV isolates. F. Comparison between clinical VNI and clinical VNIV isolates.
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detailed genetic population analysis of the two groups of isolates due to
the abundance of VNIV isolates in Europe and a wide environmental
survey recently carried out on the continent (Cogliati et al., 2016a) that
allowed several environmental isolates to be collected.
Genetic flow analysis of the most prevalent VNI genotypes in Europe
showed that four main STs are spreading in Europe (ST23, ST63, ST69,
and ST5). Germany and Italy seem to be the main fulcrum of diffusion
of both endemic (ST23 and ST63) and imported genotypes of the C.
neoformans species complex genotypes (ST69 and ST5). More detailed
investigations are needed to understand the mechanisms by which this
pathogen has crossed continents to and from Europe.
Finally, the 15 environmental C. gattii VGI and the unique VGIV
isolates investigated in the present study provided further evidence of
the endemic presence of these fungi in the Mediterranean area, con-
firming the results previously reported by Hagen et al. (2012) which
identified a cluster containing most of the VGI isolates reported from
Europe. Furthermore, our study observed that in Europe ST156 is the
most frequent VGI genotype belonging to a wider CC present in Italy
and Spain, whereas another CC (CC204) seems to be located in Greece.
Although this study provides new insights about molecular epide-
miology and population genetics of C. neoformans and C. gattii species
complexes, it is difficult to give an exhaustive picture of the situation in
Europe due to the following limits: (a) thousands of Cryptococcus iso-
lates have been isolated in Europe but at present only 6% of isolates
have been genotyped by MLST (Cogliati, 2013); (b) the sequenced
isolates were reported from only a few European and Mediterranean
countries but for most of the other European countries data are lacking;
(c) about 16% of European isolates are AD hybrids and little is known
about their genotypes; (d) environmental isolates represent a small
percentage (10%) of the total number of isolates available (Cogliati,
2013). These limits make this study a preliminary study and should be
considered a basis for future investigations. Future efforts to overcome
these limitations should be carried out in order to elucidate the real
epidemiology of Cryptococcus and cryptococcosis in Europe and in the
Mediterranean area.
In conclusion, by genetic investigation of environmental popula-
tions of Cryptococcus neoformans and Cryptococcus gattii species com-
plexes, our study has revealed that clinical and environmental isolates
in this collection of 467 isolates have different genotypic features. This
approach is a first step to understanding the genetic characteristics that
cause the shift of some genotypes from a saprophytic to a parasitic life
style.
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